Searched for
CHRONIC DISEASES
5 mid-cap stocks from different sectors with an upside potential of 13 to 24% in one year, according to analystsWhen mid-caps were rising, every concern on valuation was treated as unnecessary caution. Investors who advised patience were told they wer...- Sleeping over 8 hours daily? Senior Neurologist at Apollo Hospitals explains its underlying health issues and potential risksAre you sleeping more than 8 hours? New research has revealed that a study of nearly 500,000 people found a 'sweet spot' of 6.4 to 7.8 hour...
- When Malayalam superstar Mammootty threw Salim Kumar's shoes into a river during US trip: What happened next left the actor stunnedMalayalam cinema mourns the loss of veteran actor Salim Kumar. He passed away at 56 after a cardiac arrest. Tributes pour in, including an ...
- Salim Kumar cause of death: National Award-winning Malayalam actor dies at 56. His last Instagram post goes viralMalayalam cinema mourns the loss of National Award-winning actor Salim Kumar, who passed away at 56 after battling a liver-related illness....
- This blood test may reveal lung cancer risk long before symptomsA new blood test can predict lung cancer more than five years before diagnosis. This breakthrough offers hope for early detection in India....
- These large- and mid-cap stocks may give more than 25% return in 1 year, according to analystsFor the last few earnings seasons, the message has been: “Show me growth, I have the money.” Stocks with better-than-expected earnings saw ...
- PE wars to billion-dollar IPO dreams, hospital sector is fighting fitMajor private equity firms are vying for a stake in Cloudnine, a leading maternity and paediatric care chain. This intense competition high...
- What killed Beethoven? His own DNA finally answered after 200 years, with a bombshell twistA groundbreaking genetic study has provided new insights into the life and death of composer Ludwig van Beethoven nearly 200 years after hi...
- Health insurance company denies claim over father’s alleged alcohol history; son fights back and wins Rs 6 lakhA software engineer's father's health insurance claim was denied by HDFC ERGO due to an alleged alcohol history. The insurer repudiated the...
- The supplement your doctor hasn't mentioned yet could be quietly fighting type 2 diabetes - here's everything you need to knowFish oil benefits for type 2 diabetes: Fish oil supplementation reduced insulin resistance and improved glucose tolerance in non-obese diab...
- Good news for diabetes & BP patients: Govt cuts prices of these 30 medicines, relief may reach pharmacies soonThe National Pharmaceutical Pricing Authority (NPPA) has fixed retail prices for 30 essential drug formulations, including those for diabet...
- Homeopathy doctor shares simple tips to reduce facial and belly fat; says your future self will thank youHealth experts warn that facial puffiness and belly fat, particularly visceral fat, are serious health indicators. Dr. Sayajirao Gaikwad em...
- What if chronic nerve pain isn’t just something to block, but something to fix at the cellular level? New study reveals potential way to “recharge” nerve cells to relieve long-term painScientists are exploring a new way to treat chronic nerve pain by focusing on mitochondria, the energy-producing parts of cells. Researcher...
- Could space-grown stem cells unlock faster cancer treatments and revolutionize organ regeneration breakthroughs? NASA’s ISS experiments are revealing surprising answers about the power of microgravity medicineSpace stem cell research is rapidly changing cancer treatment and regenerative medicine worldwide. Scientists aboard the International Spac...
- Cipla is aiming for 40-50 global product filings in three years, says MD Achin GuptaCipla is charting its next growth phase with a strong focus on innovation, complex generics, and biosimilars. The company plans significant...
- Innovation, biosimilars, complex generics to drive Cipla's growth: Achin Gupta, MD & Group CEOAs Cipla approaches its centenary, the company is redefining its strategy by prioritizing innovation to amplify revenues. With ambitions to...
- Zydus Therapeutics' saroglitazar drug granted priority review by US FDAZydus Therapeutics' drug saroglitazar has received priority review from the US FDA. This drug treats primary biliary cholangitis, a liver d...
- Gene therapy for cholesterol: Initial test results cheerA new gene editing medicine, VERVE-102, offers hope for millions with heart conditions. Eli Lilly's drug showed significant reductions in b...
- Scientists say this simple thing may reverse brain aging and restore memory in weeksScientists have developed an experimental nasal spray that shows promise in reversing brain aging. This treatment targets chronic inflammat...
- Manager objects to employee’s frequent bathroom breaks at work despite medical condition. His response: ‘It is not something I can negotiate.’A manager questioned an employee's frequent bathroom breaks. The employee revealed he has Crohn's disease, a condition requiring urgent vis...
Load More
